Research Events

16 Dic 2019

Diana Buitrago - Unit of Mechanisms of Disease
Title: "Understanding the link between chromatin structure, chromosome conformation and gene regulation"
Date and Time: Monday, 16th December 2019, 12:00h.
Place: Sala de Graus, Facultat de Biologia, UB

18 Dic 2019

Lidia Mateo Ramos – Structural Bioinformatics and Network Biology
Title: "A computational toolkit to boost precision oncology with pharmacogenomics"
Date and Time: Wednesday, 18th Desember 2019. 11.00h
Room: Ramon y Cajal, Parc de Recerca Biomèdica de Barcelona (PRBB).

19 Dic 2019

Organizers: IRB Barcelona
Date: Thursday, 19th December, 12:00h
Place: Fèlix Serratosa, Parc Cientific de Barcelona

Host: Manuel Serrano, PhD., Group Leader, IRB Barcelona

 

9 Ene 2020

Elzbieta Szulca - Unit of Mechanisms of Disease
Title: "Structural insights into “acid blobs and negative noodles”"
Date and Time: Thursday, 9th January 2020, 14:00h.
Place: Room: Felix Serratosa, Parc Científic de Barcelona

14 Ene 2020

Jordi Badia - Unit of Mechanisms of Disease
Title: "Targeting the TGF-beta pathway of cancer-associated fibroblasts in colorectal cancer metastasis"
Date and Time: Tuesday, 14th January 2020, 11:00h.
Place: Aula Magna, Facultat de Biologia, Universitat de Barcelona

21 Ene 2020

Organizers: IRB Barcelona
Date: Tuesday 21 January 2020, 12.00h
Place: Felix Serratosa Hall, Parc Cientific de Barcelona

Hosts: Roger Gomis & Eduard Batlle - IRB Barcelona

Abstract

31 Ene 2020

Organizers: IRB Barcelona
Date: Friday 31 January 2020, 12.00h
Place: Auditorium, Parc Cientific de Barcelona

Host: Travis Stracker, PhD - IRB Barcelona

Abstract:

4 Feb 2020

Organizers: IRB Barcelona
Date: Tuesday, 4th Feb 2020, 12.00h
Place: Fèlix Serratosa, Parc Cientific de Barcelona

Host: Marco Milán, PhD., Group Leader, IRB Barcelona, Mechanisms of Disease Programme.

Abstract:

15 Jun 2020 - 17 Jun 2020

Cancer is the second leading cause of death worldwide, and a problem that escalates in an aging population. Although significant progress has been made in understanding the genetic and epigenetic determinants of cancer, little attention has been paid to post-transcriptional regulation of gene expression. The process of mRNA translation shapes the proteome and plays an essential role in the reprogramming of cancerous cells, holding the promise of novel anti-cancerous therapies.